Andreas Halvorsen's position in BridgeBio Pharma is currently worth $852 Million. That's 2.54% of their equity portfolio (14th largest holding). The investor owns 13.10% of the outstanding BridgeBio Pharma stock. Andreas Halvorsen started to build up the position in BridgeBio Pharma in Q2 2019. Since then they sold 4.57 Million shares. The stake costed the investor $608 Million, netting the investor a gain of 40% so far.